ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
about
Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR ModelingEquation chapter 1 section 1A new method for predicting human hepatic clearance from in vitro experimental data using molecular descriptors.New predictive models for blood-brain barrier permeability of drug-like moleculesRatio of cord to maternal serum PCB concentrations in relation to their congener-specific physicochemical properties.In Silico Prediction of Caco-2 Cell Permeability by a Classification QSAR Approach.A Genetic Algorithm Based Support Vector Machine Model for Blood-Brain Barrier Penetration Prediction.Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines.Introduction to cheminformatics.Structure-activity relationship of cyanine tau aggregation inhibitors.On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR.Going further than Lipinski's rule in drug design.Can we predict blood brain barrier permeability of ligands using computational approaches?The development of an artificial organic networks toolkit for LabVIEW.Accurate prediction of the blood-brain partitioning of a large set of solutes using ab initio calculations and genetic neural network modeling.Prediction of drug distribution in rat and humans using an artificial neural networks ensemble and a PBPK model.Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents.Polar Surface Area
P2860
Q27325561-9A227B14-6AF2-41DF-B2FD-6BA76DA7E292Q30929535-9769A72A-4343-4937-8B20-CD0302176725Q31105828-7D291665-BBA6-4FE6-AF5E-ADE3A5BC78B4Q33577354-5B6A5583-0556-4A38-AB7A-87E773828988Q34633343-51A88782-E9E2-4D71-ABE0-17C7600563E8Q36088290-62AF4B37-3429-41E6-B879-5AA3D60A51C9Q36172940-EB277F57-10E9-49BC-8C5B-31B96AE731DDQ36513179-3D891BAD-E827-43CF-9DB5-FCC6C929A511Q37144618-3BD0F3F5-B30D-4C49-8DFA-8AE63D4A3A59Q37349368-0DBF59FE-483B-4E2B-86DF-511262F11799Q37627209-D55508C4-E309-46B4-92FA-B2297A3F1F00Q37999092-DFA72558-D66C-4E25-BB24-8E5A708460DBQ38112372-4DE761DE-50D5-46FA-A764-31709008649EQ39063413-809CB0C7-A265-4A90-9382-3A9702B32FC3Q48524494-C940E249-C40F-4365-A58F-F3A71806C1BEQ51083254-BA0BBE39-DD92-4A6F-B08E-F855F58FB63AQ53387744-057F3BAB-92AA-4D21-96D3-E9D319E9141BQ56918982-DCF56E38-6E7B-4B65-8D53-0DD8D0C77C0E
P2860
ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
ADME evaluation in drug discov ...... simple molecular descriptors.
@ast
ADME evaluation in drug discov ...... simple molecular descriptors.
@en
type
label
ADME evaluation in drug discov ...... simple molecular descriptors.
@ast
ADME evaluation in drug discov ...... simple molecular descriptors.
@en
prefLabel
ADME evaluation in drug discov ...... simple molecular descriptors.
@ast
ADME evaluation in drug discov ...... simple molecular descriptors.
@en
P356
P1476
ADME evaluation in drug discov ...... simple molecular descriptors.
@en
P304
P356
10.1021/CI034134I
P577
2003-11-01T00:00:00Z